New York, February 11, 2015 -- Moody's Investor Service today placed the long term ratings of Rite Aid Corporation on review for downgrade; including its B2 Corporate Family Rating. At the same time, Rite Aid's Speculative Grade Liquidity rating of SGL-2 was affirmed. The review for downgrade was initiated following Rite Aid's announcement that it was acquiring Envision Pharmaceutical Holdings, Inc. (B3 stable) from TPG for $2 billion of which $1.8 billion will be financed with incremental debt. The transaction is expected to close in four to seven months.

Vollständigen Artikel bei Moodys lesen